Search
Overview of Inhaled Nanopharmaceuticals
Publication
Barthold S,
Kunschke N,
Murgia X,
Loretz B,
Carvalho-Wodarz C,
Lehr C
(2023)
Journal of aerosol medicine and pulmonary drug delivery, 36, 3, 144-151, 10.1089/jamp.2023.29089.sb, 37310368
Journal of aerosol medicine and pulmonary drug delivery, 36, 3, 144-151, 10.1089/jamp.2023.29089.sb, 37310368
Influence of particle size and material properties on mucociliary clearance from the airways
Publication
Henning A,
Schneider M,
Nafee N,
Muijs L,
Rytting E,
Wang X,
Kissel T,
Grafahrend D,
Klee D,
Lehr C
(2010)
Journal of aerosol medicine and pulmonary drug delivery, 23, 4, 233-241, 10.1089/jamp.2009.0806
Journal of aerosol medicine and pulmonary drug delivery, 23, 4, 233-241, 10.1089/jamp.2009.0806
Metabolic profiling of S-praziquantel: Structure elucidation using the crystalline sponge method in combination with mass spectrometry and nuclear magnetic resonance
Publication
Rosenberger L,
Jenniches J,
Essen C,
Khutia A,
Kühn C,
Marx A,
Georgi K,
Hirsch A,
Hartmann R,
Badolo L
(2022)
Drug metabolism and disposition: the biological fate of chemicals, 10.1124/dmd.121.000663, 35115299
Drug metabolism and disposition: the biological fate of chemicals, 10.1124/dmd.121.000663, 35115299
Management
Page
Management Institute Management Administrative Team Scientific Advisory Board Since its foundation in 2009, Prof. Rolf Müller leads the HIPS as its Managing Director. Since 2019, Dr. Stephanie Thomas
About
Page
Who we are The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) was established in August 2009 in collaboration between the Helmholtz Centre for Infection Research (HZI) and the Saarlan
Robotics & Liquid Handling The HIPS Technology Robotics and Liquid Handling platform is a state-of-the-art infrastructure for automated sample storage and processing. It combines high-performance auto
Analysis and Optimization of Two Film-Coated Tablet Production Processes by Computer Simulation: A Case Study
Publication
Hering S,
Schäuble N,
Buck T,
Loretz B,
Rillmann T,
Stieneker F,
Lehr C
(2021)
Processes, 9, 1, 10.3390/pr9010067
Processes, 9, 1, 10.3390/pr9010067
Surfactant-Free Glibenclamide Nanoparticles: Formulation, Characterization and Evaluation of Interactions with Biological Barriers
Publication
Arrua E,
Hartwig O,
Ho D,
Loretz B,
Murgia X,
Salomon C,
Lehr C
(2021)
Pharmaceutical research, 38, 6, 1081-1092, 10.1007/s11095-021-03056-2, 34002324
Pharmaceutical research, 38, 6, 1081-1092, 10.1007/s11095-021-03056-2, 34002324
Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis-Related Pseudomonas aeruginosa Biofilms
Publication
Thorn C,
Carvalho-Wodarz C,
Horstmann J,
Lehr C,
Prestidge C,
Thomas N
(2021)
Small (Weinheim an der Bergstrasse, Germany), 17, 24, 10.1002/smll.202100531, 33978317
Small (Weinheim an der Bergstrasse, Germany), 17, 24, 10.1002/smll.202100531, 33978317
Human Skin Permeation Enhancement Using PLGA Nanoparticles Is Mediated by Local pH Changes
Publication
Luengo J,
Schneider M,
Schneider A,
Lehr C,
Schaefer U
(2021)
Pharmaceutics, 13, 10, 10.3390/pharmaceutics13101608, 34683901
Pharmaceutics, 13, 10, 10.3390/pharmaceutics13101608, 34683901